Takeda cuts more jobs in U.S. and Japan amid slow growth

Drugmaker's net profit for current fiscal year projected to plummet 60%

20241022N Takeda

Takeda CEO Christophe Weber earned 2.08 billion yen in the year ended March. (Photo by Wataru Ito)

NORIYUKI TAKADA, TAITO KUROSE and HINAKO BANNO, Nikkei staff writers

TOKYO -- Japan's Takeda Pharmaceutical is reducing jobs on both sides of the Pacific, signaling more layoffs in the U.S. last week and offering buyouts to employees in Japan this week as it struggles under a sluggish stock price and profit margin.

Takeda plans to lay off about 80 employees by the end of March, a Worker Adjustment and Retraining Notification filed in the northeastern state of Massachusetts shows. The company had previously said it would lay off or transfer roughly 800 workers in Massachusetts and about 300 in California.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.